Friday May 15, 2020

Use of Cardiopulmonary Bypass Devices in ECMO*


In accordance with FDA’s Enforcement Policy for Extracorporeal Membrane Oxygenation and Cardiopulmonary Bypass Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency, Guidance for Industry and Food and Drug Administration Staff, which was issued on April 6, 2020, Terumo Cardiovascular is providing updates regarding our Cardiopulmonary Bypass Devices



Please visit the below links for the most up to date information in regards to Terumo’s COVID-19 Response. You will find The ECMO Update letters alongside regular press releases that relate to the topic:






*ECMO is not indicated in Canada

Do you like this story?

Back to news list